logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
04/11/2025
Stellantis (STLA.N) CEO: Currently, European supply chains lack autonomy and flexibility to respond to crises.
Latest
2 m ago
METSERA will issue non-voting preference shares to Nordea.
3 m ago
Pharmaceutical company Metsera Inc. has received a revised acquisition proposal from Novo Nordisk, valued at up to $86.20 per share. Metsera believes that Novo Nordisk's latest acquisition proposal is "superior."
3 m ago
Yichen Group (08365.HK) plans to issue shares at a discount of approximately 11.29%, with a maximum net raise of approximately HK$29.6 million.
4 m ago
American biotechnology company Metsera: The merger agreement with Pfizer (PFE.N) is still valid. According to the Pfizer acquisition agreement, Metsera and Pfizer can negotiate potential adjustment issues within two business days.
4 m ago
American biotechnology company Metsera: Novo Nordisk (NVO.N) offer is superior to Pfizer's (PFE.N) revised proposal, with the latter valuing it at a maximum of $70 per share, with a total value of approximately $8.1 billion.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.